KIG
FLNA

Kessler Investment Group’s Filana Therapeutics FLNA Stock Holding History

Kessler Investment Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,000
Closed -$5K – 122
2019
Q4 		$5K Buy
+1,000
New +$1.73K 0.01% 98

Other funds holding FLNA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Kessler Investment Group's FLNA Position: Q1 2020 in Review

Kessler Investment Group sold out of Filana Therapeutics (FLNA) in Q1 2020, closing a stake of 1,000 shares — an estimated $5K sold.

Kessler Investment Group first reported a position in FLNA in Q4 2019 and held it in 1 quarter. The position peaked at $5K in Q4 2019. 40 funds tracked by Wall St. Rank hold FLNA as of Q1 2020.

  • Kessler Investment Group reported no remaining Filana Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Kessler Investment Group sold 1,000 Filana Therapeutics shares in Q1 2020, an estimated $5K.
  • Kessler Investment Group first reported a position in Filana Therapeutics in Q4 2019 and held it in 1 quarter.
  • Kessler Investment Group's Filana Therapeutics position peaked at $5K in Q4 2019.
  • 40 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2020.

Based on Kessler Investment Group's 13F filing for Q1 2020, filed 22 Apr 2020.